|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 1:567-578, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

From the Institut de Pharmacologie et de Biologie Structurale, CNRS, 205 Route de Narbonne, 31077 Toulouse, France
To whom correspondence should be addressed: Institut de Pharmacologie et de Biologie Structurale, CNRS UMR 5089, 205 Route de Narbonne, 31077 Toulouse, France. Tel.: 33-5-61-17-55-45; Fax: 33-5-61-17-55-49; E-mail: Bernard.Monsarrat{at}ipbs.fr
The proteasome, a proteolytic complex present in all eukaryotic cells, is part of the ATP-dependent ubiquitin/proteasome pathway. It plays a critical role in the regulation of many physiological processes. The 20 S proteasome, the catalytic core of the 26 S proteasome, is made of four stacked rings of seven subunits each (
7ß7ß7
7). Here we studied the human 20 S proteasome using proteomics. This led to the establishment of a fine subunit reference map and to the identification of post-translational modifications. We found that the human 20 S proteasome, purified from erythrocytes, exhibited a high degree of structural heterogeneity, characterized by the presence of multiple isoforms for most of the
and ß subunits, including the catalytic ones, resulting in a total of at least 32 visible spots after Coomassie Blue staining. The different isoforms of a given subunit displayed shifted pI values, suggesting that they likely resulted from post-translational modifications. We then took advantage of the efficiency of complementary mass spectrometric approaches to investigate further these protein modifications at the structural level. In particular, we focused our efforts on the
7 subunit and characterized its N-acetylation and its phosphorylation site localized on Ser250.
This article has been cited by other articles:
![]() |
C. Didier, A. Merdes, J.-E. Gairin, and N. Jabrane-Ferrat Inhibition of Proteasome Activity Impairs Centrosome-dependent Microtubule Nucleation and Organization Mol. Biol. Cell, March 1, 2008; 19(3): 1220 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Drews, R. Wildgruber, C. Zong, U. Sukop, M. Nissum, G. Weber, A. V. Gomes, and P. Ping Mammalian Proteasome Subpopulations with Distinct Molecular Compositions and Proteolytic Activities Mol. Cell. Proteomics, November 1, 2007; 6(11): 2021 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Humbard, S. M. Stevens Jr., and J. A. Maupin-Furlow Posttranslational Modification of the 20S Proteasomal Proteins of the Archaeon Haloferax volcanii J. Bacteriol., November 1, 2006; 188(21): 7521 - 7530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Gomes, C. Zong, R. D. Edmondson, X. Li, E. Stefani, J. Zhang, R. C. Jones, S. Thyparambil, G.-W. Wang, X. Qiao, et al. Mapping the Murine Cardiac 26S Proteasome Complexes Circ. Res., August 18, 2006; 99(4): 362 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chapiro, S. Claverol, F. Piette, W. Ma, V. Stroobant, B. Guillaume, J.-E. Gairin, S. Morel, O. Burlet-Schiltz, B. Monsarrat, et al. Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation J. Immunol., January 15, 2006; 176(2): 1053 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Hayter, M. K. Doherty, C. Whitehead, H. McCormack, S. J. Gaskell, and R. J. Beynon The Subunit Structure and Dynamics of the 20S Proteasome in Chicken Skeletal Muscle Mol. Cell. Proteomics, September 1, 2005; 4(9): 1370 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Anderson, A. Potter, D. Baban, and K. E. Davies Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology Brain, September 1, 2003; 126(9): 2052 - 2064. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |